# Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)

> **NCT01024608** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 340 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis
- Hay Fever

## Interventions

- **DRUG:** Beclomethasone dipropionate
- **DRUG:** Placebo Nasal Aerosol

## Key facts

- **NCT ID:** NCT01024608
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-31
- **Primary completion:** 2010-02-28
- **Final completion:** 2010-02-28
- **Target enrollment:** 340 (ACTUAL)
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01024608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01024608, "Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01024608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*